The overall evidence presented positions NRN1 as a transformative therapeutic opportunity in glaucoma and other neurodegenerative disease management, representing a shift from purely pressure-based interventions to comprehensive neuroprotective strategies. This evidence concerns the gene NRN1 and neurodegenerative disease.